Laser or Injections for Diabetic Macular Edema: Why Your Doctor Chose One
Diabetic Macular Edema Treatment at a Glance
If you have diabetic macular edema (DME, swelling in the sharp-vision center of the retina), your retina specialist has two well-proven tools: eye injections and laser. In most eyes today, when the swelling sits in the very center of the macula and blurs vision, anti-VEGF injections are the usual first choice, and laser is used for leaks outside the very center or alongside injections1. The choice is not one treatment being 'good' and the other 'bad.' It rests on where the fluid sits, how much your vision is affected, and how your eye responds over time. Both are done by a retina specialist, and either one can be the right call depending on your eye.
This page explains what each treatment does, how they compare, and the practical reasons a doctor picks one, the other, or both together. It does not replace your own eye team's advice about your eye.
Keep every follow-up and injection appointment, because DME is managed over months, not in a single visit. Ask your retina specialist which pattern of edema you have and why your plan was chosen. And keep working with your primary care team on the thing that protects both eyes at once: keeping blood sugar, blood pressure, and cholesterol in a healthy range lowers the risk of vision loss from diabetes2.
What Diabetic Macular Edema Is and How Each Treatment Works
Diabetic macular edema happens when high blood sugar damages tiny retinal blood vessels so they leak fluid into the macula, the part of the retina you use for sharp, central vision, causing it to swell and blur2. Macular edema can blur or distort central vision, so that straight lines look wavy or colors look washed out, and it is found with a dilated exam and an OCT scan that measures retinal thickness3. Doctors sort DME into two patterns that drive the whole treatment decision: edema that involves the center of the macula ('center-involved') and edema that sits off to the side ('non-center-involved'). About 1 in every 15 people with diabetes develops this kind of macular swelling over time2.
VEGF is a protein that makes damaged vessels leak. Anti-VEGF medicines (such as aflibercept, ranibizumab, and bevacizumab) are injected into the eye to block that protein, reduce leakage, and can slow or even reverse vision loss, an improvement that is uncommon with laser alone1. The injection itself takes seconds after numbing drops. The catch is repetition: anti-VEGF treatment for DME usually starts as frequent injections, often about monthly at first, then spaced out as the eye stabilizes1.
Focal and grid laser photocoagulation uses a fine laser to seal leaking spots and reduce swelling, and it was the standard DME treatment before anti-VEGF drugs arrived4. A laser session is usually done in the clinic in one sitting and does not need to be repeated as often as injections. Today, focal/grid laser is mainly used for non-center-involved edema and in combination with injections to cut down how many injections an eye needs4.
Injections and Laser Side by Side
| Feature | Anti-VEGF injections | Focal/grid laser |
|---|---|---|
| Usually first for | Center-involved edema with reduced vision | Non-center-involved (off-center) edema |
| How it is given | Injection into the eye, repeated | Laser in clinic, fewer sessions |
| Main goal | Improve or stabilize central vision | Stop leakage, stabilize vision |
| Main trade-off | Frequent visits over time | Less vision recovery on its own |
Every cell here is a starting point, not a rule for your eye. Your retina specialist weighs your OCT scan, your vision, and your response before deciding.
The single biggest factor is where the swelling sits. When edema involves the center of the macula and vision is reduced, anti-VEGF injections are the standard first treatment1, because they are the option most likely to recover lost central vision. When the leakage is off-center, focal laser can seal it directly and is a reasonable first step4. Doctors also combine the two: adding laser to anti-VEGF can reduce the number of injections an eye needs over a year4. And when an eye does not respond well to injections alone, roughly 30 to 40 of every 100 eyes respond poorly to anti-VEGF, and laser or a steroid may be added4. So a doctor 'choosing laser' often means choosing it in addition to injections, not instead of them.
Risks, Results, and a Realistic Outlook
Injections are the better tool for regaining central vision, but they are not a one-time cure. Anti-VEGF drugs can reverse some vision loss in DME, an outcome that is uncommon with laser alone, but they require ongoing, repeated treatment to hold that gain1. Any injection into the eye carries small risks, and mild soreness or a small red spot on the white of the eye afterward is normal and expected. Realistic framing matters: many people keep or improve vision with consistent treatment, but no doctor can promise a specific result for your eye.
Laser is good at stopping leakage and stabilizing vision, but it recovers less lost vision than injections do. It also has its own trade-off. Older, heavier laser settings caused scarring and tissue atrophy in about 21 of every 100 treated eyes, while modern lighter, smaller-spot settings lower that risk4. If your doctor recommends laser, ask whether the newer gentler settings are being used and what part of the macula is being treated.
Neither treatment works in isolation. Managing diabetes, keeping blood sugar in a healthy range and controlling blood pressure and cholesterol, is the best way to lower the risk of vision loss, and people with diabetes should have a comprehensive dilated eye exam at least once a year2. Treatment protects the vision you have now; day-to-day diabetes control protects the vision you want years from now.
When to Call Your Retina Specialist
DME itself usually changes vision gradually, but a few symptoms mean call your retina specialist the same day rather than waiting for your next appointment: a sudden drop in vision, a shower of new floaters, flashing lights, or a dark curtain or shadow moving across your sight. After an eye injection, also call promptly if the eye becomes increasingly painful, increasingly red, or your vision drops, because those are not part of normal healing. When you cannot reach your eye team and the change is severe, seek urgent care.
DME is managed by a retina specialist, an ophthalmologist with extra training in the back of the eye, usually with repeat OCT scans to track the swelling. Between visits, your primary care doctor manages the diabetes that drives the disease. Bring your questions to each visit, and do not stop a treatment plan on your own, because DME can quietly return when treatment is paused.
Common Questions About Choosing DME Treatment
No. They answer different problems. For center-involved edema with reduced vision, injections are first-line because they can recover vision that laser usually cannot1. For off-center leakage, focal laser can seal it directly, and the two are often combined4. Your doctor picks based on where your swelling sits and how your eye responds, not on one option being universally superior.
Because anti-VEGF blocks a leak-driving protein that the diabetic retina keeps producing, so the effect wears off and the swelling can return. Treatment usually begins with frequent injections, often about monthly at first, then spaced out as the eye stabilizes1. Adding laser can reduce how many injections an eye needs over time4, which is one reason your doctor may suggest combining them.
Modern laser aims to avoid the center of vision and uses gentler settings than in the past. Older heavy settings caused scarring in about 21 of every 100 eyes, but lighter, smaller-spot laser lowers that risk4. For center-involved swelling, doctors generally prefer injections precisely to protect central vision. Ask which part of the macula is being treated and whether gentle settings are used.
Yes, and many people do. Combining focal laser with anti-VEGF injections is a recognized approach, both to treat off-center leakage and to reduce the injection burden4. Combination does not mean your first treatment failed. It is often a planned strategy to control the edema with fewer visits while protecting central vision.
More Questions, and What to Ask Your Doctor
It can, depending on your starting vision. All three common anti-VEGF drugs improve vision on average, and when vision loss is mild they work similarly, but when vision is more affected one drug (aflibercept) tended to improve vision more than the others in clinical trials1. Cost and insurance also play a role, so this is a good thing to discuss openly with your retina specialist.
Untreated diabetic macular edema can cause vision loss and blindness in people with diabetes2. That is why doctors treat center-involved edema that is affecting vision rather than watching it. If your edema is mild and off-center, your doctor may monitor it closely with scans instead of treating right away, which is a legitimate plan, not neglect.
Your retina specialist tracks two things: your vision on the eye chart and your macular thickness on OCT scans. OCT imaging measures retinal thickness and is used to find and follow the swelling3. Improvement often shows on the scan before you notice it, which is why keeping scheduled scans matters even when your vision feels stable.
Usually not in the same way a sudden, painless loss of vision is. DME tends to blur vision gradually, and it is managed with planned visits over months. But a sudden change, new floaters, flashes, or a curtain across your vision, is different and warrants a same-day call, because diabetic eyes can also develop urgent problems like bleeding or a retinal detachment.
- Is my edema center-involved or off-center, and how does that shape my plan?
- Are you recommending injections, laser, or both, and why?
- How often will I need treatment at the start, and how will we space it out?
- If laser is planned, are gentle modern settings being used, and which area is treated?
- What vision change should make me call you the same day?
- What blood sugar and blood pressure targets protect my eyes?
- American Academy of Ophthalmology (EyeNet Magazine) (2020). Diabetic Macular Edema: Diagnosis and Management.
- National Eye Institute (NEI, NIH) (2024). Diabetic Retinopathy.
- American Academy of Ophthalmology (EyeSmart) (2023). What Is Macular Edema?.
- Medicina (PMC10385537) (2023). The Role of Laser Photocoagulation in Treating Diabetic Macular Edema in the Era of Intravitreal Drug Administration: A Descriptive Review.